ZNF252P-AS1

Across TCGA pan-cancer cohorts, ZNF252P-AS1 RNA is linked to patient survival in 21 of 34 cancer types, making it the most broadly survival-associated ZNF252P-AS1 data layer.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where higher ZNF252P-AS1 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated ZNF252P-AS1 expression acts as an unfavorable survival marker, although some lineages such as BLCA and HNSC show a favorable association.

LIHC, BLCA, and UVM are the cancer types where ZNF252P-AS1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LIHC	OS	Tertile	II,III,IV	0.491	0.800	.001	70	view →
BLCA	OS	Tertile	All	0.728	0.558	.004	55	view →
UVM	DFS	Tertile	III,IV	0.192	0.774	.003	51	view →
HNSC	DFS	Tertile	IV	0.754	0.593	.005	47	view →
THYM	DFS	Tertile	All	1.000	0.621	.004	33	view →
KIRC	DFS	Tertile	All	0.513	0.672	.007	33	view →
COAD	DFS	Tertile	II,III,IV	0.569	0.739	.020	24	view →
LAML	DFS	Tertile	All	0.190	0.561	.001	24	view →
PAAD	DFS	Median	II,III,IV	0.454	0.261	.018	20	view →
KIRP	DFS	Quartile	III,IV	0.171	0.661	.010	15	view →
ESCA	OS	Quartile	II,III,IV	0.454	0.685	.040	15	view →
CESC	DFS	Quartile	III,IV	0.235	0.610	.031	14	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 21 lineages.

ZNF252P-AS1–LIHC (OS)

Open the LIHC breakdown →